Role of the PEBP4 protein in the development and metastasis of gastric cancer

Zijian Wu; Bin Liu; Xuemin Zheng; Huijing Hou; Ying Li

doi:10.18632/oncotarget.15255

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Expression of Concern

This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.

Role of the PEBP4 protein in the development and metastasis of gastric cancer

Zijian Wu _, Bin Liu, Xuemin Zheng, Huijing Hou and Ying Li

PDF | HTML | How to cite

Oncotarget. 2017; 8:18177-18184. https://doi.org/10.18632/oncotarget.15255

Metrics: PDF 2918 views | HTML 1938 views | ?

Abstract

Zijian Wu1,*, Bin Liu1,*, Xuemin Zheng2, Huijing Hou1, Ying Li3

1Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, China

2Tianjin Institute of Pharmaceutical Research, China

3Tianjin Neurological Institute, Tianjin Medical University General Hospital, China

*These authors have contributed equally to this work

Correspondence to:

Zijian Wu, email: [email protected]

Ying Li, email: [email protected]

Keywords: gastric cancer, PEBP4, cancer immigration, cancer invasion

Received: November 02, 2016 Accepted: December 28, 2016 Published: February 10, 2017

ABSTRACT

Phosphatidylethanolamine-binding protein 4 (PEBP4) has previously been reported to be upregulated in various cancers. However, the physiological functions of PEBP4 in gastric cancer are still unknown. Aiming to clarify the properties and role of PEBP4 in the development and invasion of gastric cancer, we performed several biological assays and a knockdown assay. The expression level of PEBP4 was shown to be significantly upregulated in gastric cancer tissue samples, and knockdown of the expression of PEBP4 induced significant inhibitory effects on cell proliferation, migration and invasiveness. In addition, it was demonstrated that PEBP4 was associated with the development and invasion of gastric cancer cells through activation of the PI3K/Akt signaling pathway. Our findings supported the hypothesis that PEBP4 might be a novel potential drug target for the treatment of gastric cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15255

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Role of the PEBP4 protein in the development and metastasis of gastric cancer

Abstract